These Two Companies' Stocks Soared Today With FDA Approval and Higher Opertating Income - AVNR, KSP

AVANIR Pharmaceuticals, Inc. (Nasdaq:AVNR) today announced a management conference call to discuss the FDA approval of NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) by the U.S. Food and Drug Administration (FDA). The call was earlier today, Monday November 1, 2010 at 5:15 a.m. Pacific time / 8:15 a.m. Eastern time.